Thread: Two 1998 year-long trials showed that Finasteride DOUBLES sexual dysfunction

Ahhh... Jeez.

https://www.miamiherald.com/news/nat...130815949.html

In 1998, two year-long trials were conducted with more than 1,500 men ages 18 to 41 receiving either Propecia or a placebo. The rate of sexual dysfunction in the finasteride group was about double that of the placebo group (4.2 percent compared with 2.2 percent). Because this trial was designed to study the hair-restoring qualities of finasteride, and the assessment of sexual side effects does not appear to have been rigorously conducted, the extent of the side effects may very well have been underreported.

The study can be read here: https://pubmed.ncbi.nlm.nih.gov/9777765/

However, it does require you to purchase the rights to get the full study.

Just trying to look out for the safety of all miscers.

in for op's daily anti fin threads. looks like sandman replaced his ex gf with this bs. somehow op is still green...

Originally Posted by jasticus

Lol this is just pure fud

At what percent would you not take the risk?

I’d say 10% and I wouldn’t take the risk.

I wish there were more studies on this.

Originally Posted by Lb54TG

At what percent would you not take the risk?

I’d say 10% and I wouldn’t take the risk.

I wish there were more studies on this.

Merck - the creator of Finasteride - underreported the side effects of the drug. Initially the figure was at 3.8%, but they used insidious/dubious research tactics to underreport. The "0.3% experience side effects" is totally misleading.

You can read about it in this Reuters report.

https://www.reuters.com/investigates...recy-propecia/

The revised label retained the original label’s statement that 3.8% of the 945 men taking Propecia in the first year of research experienced sexual side effects. But the company added that, among the 323 men who took the drug for all five years of the extended study, “the incidence of each type [of sexual side effect] decreased to no more than 0.3% by the fifth year of treatment.”

A 60-page motion plaintiffs’ lawyers filed in Cogan’s court alleges that Merck’s 0.3% figure on the revised label underreports the number of men who experienced sexual side effects during the extended study. The passages of the motion pertaining to the study were redacted. However, Reuters was able to view the blacked-out material after copying it from a digital version of the motion and pasting it into a document in a different format.

Before the 2002 label change, Dr Keith Kaufman, clinical head of Propecia, discussed different ways of interpreting clinical trial data, the plaintiffs’ court filing says. The 0.3% figure is “totally misleading” because, by the fifth year, “you have weeded out the dropouts with the sexual [adverse experiences],” the motion quotes him as saying. The legal filing does not specify who received Kaufman’s correspondence.

2.2% of anything negative in the medical field is A LOT, 4+% should be recalled.

What if you just take it every other day? That's all that's needed anyway. Source: Hair Loss Talk on YouTube where one of the Drs is from the original studies of both fin and min.

Originally Posted by leoaa777

2.2% of anything negative in the medical field is A LOT, 4+% should be recalled.

It's significant, that's for sure.